Iโm Head of Investor Relations at Ultimovacs, a public listed biotech company developing a therapeutic cancer vaccine (five Phase 2 clinical trials @ 100+ hospitals in 15 countries) and a novel tech platform for cancer treatment.
Angel investing in impact, sustainability and tech startups as Managing Partner Farmhouse Capital ๐ฑ and Venture Partner at a global VC, Antler ๐
Previously SF, currently Oslo/Nordics
๐ณ๐ด๐ช๐บ๐บ๐ธ
๐: ยซThe Breakthrough - Immunotherapy and the race to cure cancerยป by Charles Graeber
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
May 07, 2024 | 2,233 | +1 | +0.1% |
February 13, 2024 | 2,232 | +2 | +0.1% |
November 24, 2023 | 2,230 | +1 | +0.1% |
October 24, 2023 | 2,229 | +1 | +0.1% |
September 14, 2023 | 2,228 | -1 | -0.1% |
August 19, 2023 | 2,229 | -1 | -0.1% |
August 13, 2023 | 2,230 | +1 | +0.1% |
June 16, 2023 | 2,229 | +2 | +0.1% |
April 08, 2023 | 2,227 | +1 | +0.1% |
March 21, 2023 | 2,226 | +1 | +0.1% |